21 May 2018

Vitamin C a Core Element in Vast UdeS Research Project

What if vitamin C reduced the effects of septic shock – an often deadly systemicFrançois Lamontagne, Université de Sherbrooke inflammatory response? This is the avenue to be explored by the LOVIT clinical study, led by François Lamontagne, professor-researcher at the Université de Sherbrooke and the Centre de recherche du CHUS, and also critical care physician at the CIUSSS de l’Estrie CHUS.

800 Canadian and European patients will be participating in the research project, which aims to study the effect of heavy concentrations of vitamin C administered intravenously on mortality and the need for intensive care of patients with septic shock.

LOVIT has obtained a $2.8M grant from a Canadian non-profit organization and is assembling a team of fundamental specialists and researchers based at the University of Toronto and Queen’s University, as well as at the Université de Sherbrooke.

» Source and photo credit: Université de Sherbrooke

Back to the news

Leave a Reply

Your email address will not be published. Required fields are marked *

Sherbrooke Innopole’s mandate ends on March 31, 2024. We invite you to contact Entreprendre Sherbrooke or the Service du développement économique of the Ville de Sherbrooke for further services.
Thank you to all Sherbrooke industrial and technological businesses, as well as to all our partners for the trust granted since 2009!